Target intelligence / Profile preview

Granulocyte-macrophage colony-stimulating factor receptor and Interleukin-3 receptor (GM-CSF receptor (GM-CSFR) and IL-3 receptor (IL-3R))

Target
GM-CSF receptor (GM-CSFR) and IL-3 receptor (IL-3R)
Molecular classification
Receptor, Type I cytokine receptor, Class I hematopoietic cytokine receptor superfamily
01

Overview

Granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) and interleukin-3 receptor (IL-3R) are closely related type I cytokine receptors that regulate hematopoiesis and immune responses[7][3][9][6]. Both receptors are multimeric complexes composed of a ligand-specific alpha subunit (CSF2RA for GM-CSF; IL3RA for IL-3), and a shared common beta subunit (CSF2RB, also called βc or CD131), which is essential for high-affinity binding and signal transduction[5][7][4][2]. Upon ligand binding, the receptors oligomerize, resulting in the activation of downstream signaling cascades such as JAK2/STAT5, ERK, and PI3K, which control cell survival, proliferation, and differentiation[6][3][9]. These receptors play key roles in the proliferation and differentiation of hematopoietic progenitors, the function of mature myeloid cells, and the pathogenesis of inflammatory, allergic, and malignant diseases. Because of their roles in disease, especially in cancer and autoimmune disorders, both are considered important therapeutic targets, with monoclonal antibodies and other inhibitors in various stages of development and clinical use[6][7]. Note on correctness: There is a problem with the query as stated: “GM-CSF and IL-3 receptors” is not a single target but refers to two closely related, though distinct, receptors. Often, the term "βc family" or "common beta subunit (CSF2RB) receptor complex" is used to describe the shared subunit system for GM-CSF, IL-3, and IL-5, but therapeutically and structurally, GM-CSF receptor and IL-3 receptor are considered separate targets that share a key signaling component[7][5][4]. Thus, the entry as “GM-CSF and IL-3 receptors” is overly broad and conflates two closely related, yet distinct, targets. If specificity is needed, these should be captured as two targets: "Granulocyte-macrophage colony-stimulating factor receptor" and "Interleukin-3 receptor", each with their respective details.

Other names
CSF2 receptor (for GM-CSF receptor)CD116 (for GM-CSF receptor, α-subunit)Cytokine receptor common beta subunit (βc, CD131)IL3RA / CD123 (for IL-3 receptor, α-subunit)GM-CSF/IL-3/IL-5 receptor family
02

Mechanism of action

Antagonism or inhibition of ligand (GM-CSF or IL-3) binding to its receptor Antagonism or inhibition of βc dimerization and signal transduction Downregulation of JAK2/STAT5 or other downstream signaling

03

Biological functions

Signal transductionHematopoiesisImmune responseCell proliferationCell survivalDifferenti-ation of myeloid and other hematopoietic lineages
04

Disease associations

Cancer (especially leukemia)InflammationAutoimmune diseaseAllergic diseaseInfection
05

Safety considerations

Risk of immune suppressionRisk of opportunistic infectionsMyelosuppression (reduction of blood cell lineages)Potential impact on host defense and tissue repair
06

Interacting drugs

Mavrilimumab (GM-CSF receptor inhibitor)

2 more in the full profile.

07

Biomarkers

Surface expression of CD116 (GM-CSFR alpha) and CD123 (IL-3R alpha) on leukemic cells as diagnostic/prognostic biomarkers in acute myeloid leukemiaβc (CD131) expression for evaluating target engagement

Beyond the preview

Go deeper on Granulocyte-macrophage colony-stimulating factor receptor and Interleukin-3 receptor (GM-CSF receptor (GM-CSFR) and IL-3 receptor (IL-3R)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Granulocyte-macrophage colony-stimulating factor receptor and Interleukin-3 receptor (GM-CSF receptor (GM-CSFR) and IL-3 receptor (IL-3R)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call